European Companies Search Engine
Registration · Managing Director: Adel Bensyde · Address · Capital: €25,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb 24 Sept 2021 German Trade Register Announcements, Germany
Overview
Text
HRB 45691: Adel Pharma GmbH,
Densborn, In den Feldern 2, 54570 Densborn
. Limited liability company. Articles of Association of 31 August 2021. Business address: In the
Unnamed street ??, 54570 Densborn, Germany
. Purpose: Trade in medicinal products, medicinal products for human use, veterinary medicinal products, prescription-only medicinal products, over-the-counter medicinal products, medical devices and food supplements, as well as the export of medicinal products to third countries, e.B. to Morocco/Africa. Common stock capital: 25.000,00 EUR. General representation regulation: If only one managing director is appointed, he represents the company alone. If several managing directors have been appointed, the company is represented by two managing directors or by a managing director together with an authorized signatory. Managing Director: Bensyde, Adel, Cologne, **??.??.????, authorized to represent individually with the authority to conclude legal transactions on behalf of the company with himself in his own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Adel Pharma GmbH, Densborn, Germany.